The global kyphoplasty market size reached USD 712.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,069.4 Million by 2033, exhibiting a growth rate (CAGR) of 4.39% during 2025-2033. The rising prevalence of osteoporosis across the globe, the growing preference for minimally invasive surgical procedures among patients, and various technological advancements in the healthcare sector represent some of the key factors driving the market.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 712.4 Million |
Market Forecast in 2033 | USD 1,069.4 Million |
Market Growth Rate (2025-2033) |
4.39%
|
Kyphoplasty is a minimally invasive surgical procedure to treat vertebral compression fractures (VCFs) in the spine. VCFs are fractures of the vertebrae, which are the small bones that make up the spine. These fractures can occur due to osteoporosis, trauma, or other medical conditions. During kyphoplasty, a small incision is made in the back, and a narrow tube is inserted into the fractured vertebra. A small balloon is then inserted through the tube and inflated to create a cavity inside the vertebra. It requires small incisions and involves less pain, scarring, and recovery time than traditional open surgery. The procedure is performed under local or general anesthesia and has a high success rate, with most patients experiencing significant pain relief and improved mobility after the procedure. Owing to these benefits, kyphoplasty is widely preferred by patients and professionals across the globe.
The market is primarily driven by the growing prevalence of osteoporosis and vertebral compression fractures (VCFs). Osteoporosis is a common condition, particularly among older adults, which is escalating the demand for kyphoplasty procedures. In addition, the shifting preferences for minimally invasive procedures represent another major growth-inducing factor. Kyphoplasty is a minimally invasive procedure that requires small incisions and involves less pain, scarring, and recovery time than traditional open surgery. Besides this, the rising awareness regarding the diagnosis of VCFs is also contributing to market growth. VCFs can be difficult to diagnose, and many patients may not be aware they have the condition. However, with improved imaging techniques and greater awareness of the symptoms and risk factors for VCFs, patients are adopting kyphoplasty as a treatment option. Moreover, the development of improved kyphoplasty devices with radiofrequency ablation or balloon kyphoplasty has made the procedure safer and more effective, thus accelerating the adoption among physicians and patients. Furthermore, the increasing health reimbursement policies are also propelling market growth. Reimbursement policies for kyphoplasty procedures vary by region, and public and private health insurers cover the cost of the procedure. This has helped to increase access to kyphoplasty among patients with weaker financial positions. Apart from this, the rising disposable incomes, the increasing healthcare expenditure, and the developing medical infrastructure are some of the other factors creating a favorable market outlook across the globe.
IMARC Group provides an analysis of the key trends in each segment of the global kyphoplasty market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product, indication, application, and end user.
Product Insights:
The report has provided a detailed breakup and analysis of the kyphoplasty market based on the product. This includes balloon catheters, bone access devices, cement application products, bone cement, cement mixing systems, and instruments. According to the report, bone access devices represented the largest segment.
Indication Insights:
A detailed breakup and analysis of the kyphoplasty market based on the indication has also been provided in the report. This includes osteoporosis and others. According to the report, osteoporosis accounted for the largest market share.
Application Insights:
The report has provided a detailed breakup and analysis of the kyphoplasty market based on the application. This includes balloon kyphosis, spinal fractures, and vertebral alignment restoration. According to the report, spinal fractures represented the largest segment.
End User Insights:
A detailed breakup and analysis of the kyphoplasty market based on the end user has also been provided in the report. This includes hospitals and clinics and ambulatory surgical centers. According to the report, hospitals and clinics accounted for the largest market share.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for kyphoplasty. Some of the factors driving the North America kyphoplasty market included its aging population, technological advancements and rising healthcare expenditure.
The report has also provided a comprehensive analysis of the competitive landscape in the global kyphoplasty market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alphatec Holdings TNC, Biopsybell S.r.l., Globus Medical Inc, Izi Medical Products LLC, Johnson & Johnson, Joline GmbH & Co. KG, Medtronic plc, Merit Medicals Systems, Seawon Meditech Co. Ltd., SOMATEX Medical Technologies Gm (Hologic Inc.), Spinal Elements Inc., Zavation Medical Products LLC,etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical and Forecast Trends, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment:
|
Products Covered | Balloon Catheters, Bone Access Devices, Cement Application Products, Bone Cement, Cement Mixing Systems, Instruments |
Indications Covered | Osteoporosis, Others |
Applications Covered | Kyphosis, Spinal Fractures, Vertebral Alignment Restoration |
End Users Covered | Hospitals and Clinics, Ambulatory Surgical Centers |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Alphatec Holdings TNC, Biopsybell S.r.l., Globus Medical Inc, Izi Medical Products LLC, Johnson & Johnson, Joline GmbH & Co. KG, Medtronic plc, Merit Medicals Systems, Seawon Meditech Co. Ltd., SOMATEX Medical Technologies Gm (Hologic Inc.), Spinal Elements Inc., Zavation Medical Products LLC,etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |